Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | f10k2022_biondvax.htm iXBRL | 10-K | 1644989 |
| 2 | ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTD | f10k2022ex3-1_biondvax.htm | EX-3.1 | 310242 |
| 3 | DESCRIPTION OF SECURITIES | f10k2022ex4-1_biondvax.htm | EX-4.1 | 100664 |
| 4 | ADDENDUM TO EMPLOYMENT AGREEMENT DATED MAY 28, 2015, BETWEEN BIONDVAX PHARMACEUT | f10k2022ex10-8_biondvax.htm | EX-10.8 | 567 |
| 5 | ADDENDUM TO EMPLOYMENT AGREEMENT DATED APRIL 1, 2012, BETWEEN BIONDVAX PHARMACEU | f10k2022ex10-9_biondvax.htm | EX-10.9 | 574 |
| 6 | EMPLOYMENT AGREEMENT DATED SEPTEMBER 5, 2018, BETWEEN BIONDVAX PHARMACEUTICALS L | f10k2022ex10-10_biondvax.htm | EX-10.10 | 7627 |
| 7 | AMENDMENT AGREEMENT DATED AUGUST 9, 2022, TO FINANCE CONTRACT DATED JUNE 19, 201 | f10k2022ex10-21_biondvax.htm | EX-10.21 | 13758 |
| 8 | CODE OF CONDUCT | f10k2022ex14-1_biondvax.htm | EX-14.1 | 71757 |
| 9 | CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M | f10k2022ex23-1_biondvax.htm | EX-23.1 | 2508 |
| 10 | CERTIFICATION | f10k2022ex31-1_biondvax.htm | EX-31.1 | 8676 |
| 11 | CERTIFICATION | f10k2022ex31-2_biondvax.htm | EX-31.2 | 8532 |
| 12 | CERTIFICATION | f10k2022ex32-1_biondvax.htm | EX-32.1 | 3690 |
| 13 | CERTIFICATION | f10k2022ex32-2_biondvax.htm | EX-32.2 | 3809 |
| 14 | GRAPHIC | image_001.jpg | GRAPHIC | 9702 |
| 15 | GRAPHIC | ex10-8_001.jpg | GRAPHIC | 178331 |
| 16 | GRAPHIC | ex10-9_001.jpg | GRAPHIC | 179887 |
| 17 | GRAPHIC | ex10-10_001.jpg | GRAPHIC | 273046 |
| 18 | GRAPHIC | ex10-10_002.jpg | GRAPHIC | 288290 |
| 19 | GRAPHIC | ex10-10_003.jpg | GRAPHIC | 263044 |
| 20 | GRAPHIC | ex10-10_004.jpg | GRAPHIC | 274468 |
| 21 | GRAPHIC | ex10-10_005.jpg | GRAPHIC | 249743 |
| 22 | GRAPHIC | ex10-10_006.jpg | GRAPHIC | 251497 |
| 23 | GRAPHIC | ex10-10_007.jpg | GRAPHIC | 334137 |
| 24 | GRAPHIC | ex10-10_008.jpg | GRAPHIC | 129604 |
| 25 | GRAPHIC | ex10-10_009.jpg | GRAPHIC | 153729 |
| 26 | GRAPHIC | ex10-10_010.jpg | GRAPHIC | 34446 |
| 27 | GRAPHIC | ex10-21_001.jpg | GRAPHIC | 46686 |
| 28 | GRAPHIC | ex10-21_002.jpg | GRAPHIC | 47656 |
| 29 | GRAPHIC | ex10-21_003.jpg | GRAPHIC | 166671 |
| 30 | GRAPHIC | ex10-21_004.jpg | GRAPHIC | 155828 |
| 31 | GRAPHIC | ex10-21_005.jpg | GRAPHIC | 104609 |
| 32 | GRAPHIC | ex10-21_006.jpg | GRAPHIC | 189047 |
| 33 | GRAPHIC | ex10-21_007.jpg | GRAPHIC | 37402 |
| 34 | GRAPHIC | ex10-21_008.jpg | GRAPHIC | 162735 |
| 35 | GRAPHIC | ex10-21_009.jpg | GRAPHIC | 142348 |
| 36 | GRAPHIC | ex10-21_010.jpg | GRAPHIC | 200852 |
| 37 | GRAPHIC | ex10-21_011.jpg | GRAPHIC | 194943 |
| 38 | GRAPHIC | ex10-21_012.jpg | GRAPHIC | 159967 |
| 39 | GRAPHIC | ex10-21_013.jpg | GRAPHIC | 179502 |
| 40 | GRAPHIC | ex10-21_014.jpg | GRAPHIC | 157974 |
| 41 | GRAPHIC | ex10-21_015.jpg | GRAPHIC | 198128 |
| 42 | GRAPHIC | ex10-21_016.jpg | GRAPHIC | 42782 |
| 43 | GRAPHIC | ex10-21_017.jpg | GRAPHIC | 45905 |
| Complete submission text file | 0001213900-23-030228.txt | 12997520 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 44 | XBRL SCHEMA FILE | adr-20221231.xsd | EX-101.SCH | 72100 |
| 45 | XBRL CALCULATION FILE | adr-20221231_cal.xml | EX-101.CAL | 27307 |
| 46 | XBRL DEFINITION FILE | adr-20221231_def.xml | EX-101.DEF | 234664 |
| 47 | XBRL LABEL FILE | adr-20221231_lab.xml | EX-101.LAB | 511120 |
| 48 | XBRL PRESENTATION FILE | adr-20221231_pre.xml | EX-101.PRE | 250201 |
| 111 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2022_biondvax_htm.xml | XML | 488017 |
IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37353 | Film No.: 23824012
SIC: 2836 Biological Products, (No Diagnostic Substances)
